Pentraxin 3 (PTX3) Is Associated with Severe Sepsis and Fatal Disease in Emergency Room Patients with Suspected Infection: A Prospective Cohort Study

Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study

(2013) R. Uusitalo-Seppälä et al.   JOURNAL OF INTERNAL MEDICINE

Role of plasma bactericidal/permeability-increasing protein, group IIA phospholipase A2, C-reactive protein, and white blood cell count in the early detection of severe sepsis in the emergency department

(2012) Raija Uusitalo-Seppälä et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma

(2011) E. P. Diamandis et al.   CLINICAL CANCER RESEARCH

Pentraxins and Atherosclerosis: The Role of PTX3

(2011) Cecilia Garlanda et al.   CURRENT PHARMACEUTICAL DESIGN

High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica

(2011) T. K. Outinen et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients

(2011) M. Vanska et al.   HAEMATOLOGICA

High Plasma Level of Long Pentraxin 3 (PTX3) Is Associated with Fatal Disease in Bacteremic Patients: A Prospective Cohort Study

(2011) Reetta Huttunen et al.   PLoS One

Early detection of severe sepsis in the emergency room: Diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6

(2011) Raija Uusitalo-Seppälä et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality

(2010) Tommaso Mauri et al.   INTENSIVE CARE MEDICINE

Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations

(2009) Kazumi Yamasaki et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity*

(2009) Tommaso Mauri et al.   CRITICAL CARE MEDICINE

Biomarkers of sepsis

(2009) John C. Marshall et al.   CRITICAL CARE MEDICINE

Effect of Procalcitonin-Guided Treatment in Patients with Infections: a Systematic Review and Meta-Analysis

(2009) H. Tang et al.   INFECTION

Is C-reactive protein a good prognostic marker in septic patients?

(2009) Joana Silvestre et al.   INTENSIVE CARE MEDICINE

Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis

(2009) Jiri F.P. Wagenaar et al.   JOURNAL OF INFECTION

PTX3 predicts severe disease in febrile patients at the emergency department

(2009) Martijn D. de Kruif et al.   JOURNAL OF INFECTION

EFFICACY OF PROCALCITONIN IN THE EARLY DIAGNOSIS OF BACTERIAL INFECTIONS IN A CRITICAL CARE UNIT

(2009) Akiko Nakamura et al.   SHOCK

Pentraxins, humoral innate immunity and tissue injury

(2008) Angelo A Manfredi et al.   CURRENT OPINION IN IMMUNOLOGY

The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity

(2008) Barbara Bottazzi et al.   IMMUNOLOGICAL REVIEWS

PENTRAXIN 3 AND C-REACTIVE PROTEIN IN SEVERE MENINGOCOCCAL DISEASE

(2008) Tom Sprong et al.   SHOCK

Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: We could go faster

(2007) Massimo Zambon et al.   JOURNAL OF CRITICAL CARE